此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy (BIMRT)

2012年3月7日 更新者:British Columbia Cancer Agency

Long Term Outcomes of A Multicentre Controlled Clinical Trial of Breast Irradiation Using Intensity-Modulated Radiation Therapy

The purpose of this study is to evaluate the frequency of chronic breast pain about 8 years after the delivery of the radiation treatment, and to compare the frequency between subjects that received breast Intensity-Modulated Radiation Therapy (IMRT) and those that received standard wedge radiotherapy. The cosmetic result, meaning how similar is the treated breast compared to the non-treated breast, will be assessed. Also, the occurrence of delayed radiation treatment side effects including tiny red vessels in the skin, breast indurations (hardening of the skin), skin discoloration, oedema (swelling of the breast), and skin dryness will be captured.

研究概览

详细说明

The Canadian breast IMRT clinical trial accrued 358 subjects between July 2003 to March 2005. Those subjects were randomised between standard radiotherapy using 2D wedge compensation and breast IMRT. Subjects were treated in Toronto, Ontario, or in Victoria, British Columbia. Subjects and assessors were carefully blinded to the treatment arm. The clinical trial was funded by the Canadian Institute for Health Research (CIHR) and one of the four objectives of the application was to "To record late skin toxicity occurrence, fibrosis and telangiectasia, in women receiving breast IMRT and conventional irradiation technique".

The investigators are proposing to invite women who participated in the trial to return to their treatment centre during 2011-2013 for a follow-up assessment at eight years after randomisation to record relevant long-term outcomes including the effect of improved homogeneity with IMRT on the occurrence of late radiation therapy side-effects cosmetic outcome and Quality of Life.

研究类型

观察性的

注册 (预期的)

314

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • British Columbia
      • Victoria、British Columbia、加拿大、V8R6V5
        • BCCA - Vancouver Island Cancer Centre
    • Ontario
      • Toronto、Ontario、加拿大、M4N 3M5
        • Odette Cancer Centre

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

女性

取样方法

概率样本

研究人群

Breast cancer subjects treated in Toronto, Ontario, or in Victoria, British Columbia that participated in The Canadian breast IMRT clinical trial between July 2003 to March 2005.

描述

Inclusion Criteria:

  • Subject randomised in the initial breast IMRT randomized trial will be eligible for this new study

Exclusion Criteria:

  • Subjects who have experienced a recurrence (invasive or in situ) in the breast will be excluded.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:仅案例
  • 时间观点:追溯

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Does breast IMRT reduces the occurrence of chronic breast pain after radiation therapy.
大体时间:8 years post RT
A Self pain measurement questionnaire using Visual analog scale (VAS) The nurse coordinator will assess the subject's breast pain due to radiation using the CTCAE 4.0 scale Subjects will complete a Self pain measurement short form of the McGill pain questionnaire
8 years post RT

次要结果测量

结果测量
措施说明
大体时间
Does breast IMRT reduce the occurrence of late radiation therapy side effects
大体时间:8 years post RT

A EORTC Breast Cancer Rating System for the cosmetic assessment RTOG/EORTC Late Radiation Morbidity Scoring Scheme Cosmetic outcome of the treated breast as compared with the untreated using the Harvard criteria Digital images (photographs) will be taken of the treated and untreated breasts.

Breast Cancer Treatment Outcome Scale (BCTOS) questionnaire

8 years post RT
Does breast IMRT effect long term QOL
大体时间:8 Years post RT

A EORTC Breast Cancer Rating System for the cosmetic assessment RTOG/EORTC Late Radiation Morbidity Scoring Scheme Cosmetic outcome of the treated breast as compared with the untreated using the Harvard criteria Digital images (photographs) will be taken of the treated and untreated breasts.

Breast Cancer Treatment Outcome Scale (BCTOS) questionnaire

8 Years post RT
Does IMRT effect local recurrence rates, overall and disease free survivals.
大体时间:8 years post RT
Data collection of local recurrences, overall and disease free survivals.
8 years post RT

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jean-Philippe Pignol, MD、Odette Cancer Centre
  • 首席研究员:Pauline Truong, MD、BCCA - Vancouver Island Cancer Centre
  • 首席研究员:Ivo Olivotto, MD、BCCA - Vancouver Island Cancer Centre

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年3月1日

初级完成 (预期的)

2013年5月1日

研究完成 (预期的)

2013年5月1日

研究注册日期

首次提交

2012年2月15日

首先提交符合 QC 标准的

2012年2月22日

首次发布 (估计)

2012年2月23日

研究记录更新

最后更新发布 (估计)

2012年3月9日

上次提交的符合 QC 标准的更新

2012年3月7日

最后验证

2012年3月1日

更多信息

与本研究相关的术语

其他研究编号

  • BCCABreastIMRT

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅